Medical Properties Trust Closes Sale of Remaining Australia Facilities

Rhea-AI Summary

Medical Properties Trust, Inc. closes sale of Australian facilities for AUD$470 million ($305 million) to reduce debt and increase cash availability. Also repurchased £50 million of Unsecured Notes at a repurchase yield averaging almost 13%. MPT maintains $950 million of immediate liquidity.

Positive

• Medical Properties Trust, Inc. closes sale of Australian facilities for AUD$470 million ($305 million) to reduce debt and increase cash availability. MPT maintains $950 million of immediate liquidity.

Negative

• None.

BIRMINGHAM, Ala.--(BUSINESS WIRE)-- Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced the closing of the sale of its four remaining Australian facilities to HMC Capital at a 5.7% cash cap rate for around AUD$470 million (approximately $305 million), which will be used to reduce the balance of MPT’s revolving credit facility and to increase cash availability. The Company has also repurchased since the end of the second quarter, in a series of open market transactions, approximately £50 million of its 2.550% Unsecured Notes due in December 2023 at a repurchase yield averaging almost 13%. Following these actions, MPT maintains approximately $950 million of immediate liquidity, which is sufficient to address all remaining 2023 and 2024 debt maturities before considering anticipated dividend savings and expected proceeds from the sale of three Connecticut facilities leased to Prospect.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 444 facilities and approximately 44,000 licensed beds as of June 30, 2023. Since the end of the second quarter, the Company has sold seven facilities with approximately 1,000 beds and now owns properties in nine countries across three continents. MPT’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our strategies, objectives, future expansion and development activities, asset sales, expected returns on investments and expected financial performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the economic, political and social impact of, and uncertainty relating to, potential impact from health crises (like COVID-19); (ii) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us, especially as a result of the adverse economic impact of the COVID-19 pandemic, and government regulation of hospitals and healthcare providers in connection with same (as further detailed in our Current Report on Form 8-K filed with the SEC on April 8, 2020); (iii) our expectations regarding annual guidance for net income and NFFO per share; (iv) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (v) the nature and extent of our current and future competition; (vi) macroeconomic conditions, such as a disruption of or lack of access to the capital markets or movements in currency exchange rates; (vii) our ability to obtain debt financing on attractive terms or at all, which may adversely impact our ability to pursue acquisition and development opportunities and pay down, refinance, restructure or extend our indebtedness as it becomes due; (viii) increases in our borrowing costs as a result of changes in interest rates and other factors; (ix) international, national and local economic, real estate and other market conditions, which may negatively impact, among other things, the financial condition of our tenants, lenders and institutions that hold our cash balances, and may expose us to increased risks of default by these parties; (x) factors affecting the real estate industry generally or the healthcare real estate industry in particular; (xi) our ability to maintain our status as a REIT for federal and state income tax purposes; (xii) federal and state healthcare and other regulatory requirements, as well as those in the foreign jurisdictions where we own properties; (xiii) the value of our real estate assets, which may limit our ability to dispose of assets at attractive prices or obtain or maintain equity or debt financing secured by our properties or on an unsecured basis; (xiv) the ability of our tenants and operators to operate profitably and generate positive cash flow, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (xv) potential environmental contingencies and other liabilities; (xvi) the risk that the expected sale of three Connecticut hospitals currently leased to Prospect does not occur; (xvii) the risk that MPT is unable to monetize its investment in PHP at full value within a reasonable time period or at all; (xviii) the risk that other property sales, loan repayments, and other capital recycling transactions do not occur; (xix) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; and (xx) the risks and uncertainties of litigation.

The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 and as updated in our quarterly reports on Form 10-Q. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231010119066/en/

Drew Babin, CFA, CMA

Senior Managing Director of Corporate Communications

Medical Properties Trust, Inc.

(646) 884-9809

dbabin@medicalpropertiestrust.com

Source: Medical Properties Trust, Inc.

FAQ

What is the purpose of the sale of Australian facilities?

The sale of Australian facilities is to reduce debt and increase cash availability.

How much did Medical Properties Trust, Inc. receive from the sale of Australian facilities?

Medical Properties Trust, Inc. received AUD$470 million ($305 million) from the sale of Australian facilities.

How much liquidity does Medical Properties Trust, Inc. currently have?

Medical Properties Trust, Inc. currently has $950 million of immediate liquidity.

What did Medical Properties Trust, Inc. repurchase?

Medical Properties Trust, Inc. repurchased £50 million of Unsecured Notes.

What is the repurchase yield for the Unsecured Notes?

The repurchase yield for the Unsecured Notes averaged almost 13%.